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This study aimed to evaluate the abilities of plant and algae lectins to inhibit planktonic growth and biofilm formation in bacteria
and yeasts. Initially, ten lectins were tested on Staphylococcus epidermidis, Staphylococcus aureus, Klebsiella oxytoca, Pseudomonas
aeruginosa, Candida albicans, and C. tropicalis at concentrations of 31.25 to 250𝜇g/mL.The lectins from Cratylia floribunda (CFL),
Vataireamacrocarpa (VML),Bauhinia bauhinioides (BBL),Bryothamnion seaforthii (BSL), andHypneamusciformis (HML) showed
activities against at least one microorganism. Biofilm formation in the presence of the lectins was also evaluated; after 24 h of
incubation with the lectins, the biofilms were analyzed by quantifying the biomass (by crystal violet staining) and by enumerating
the viable cells (colony-forming units).The lectins reduced the biofilmbiomass and/or the number of viable cells to differing degrees
depending on the microorganism tested, demonstrating the different characteristics of the lectins. These findings indicate that the
lectins tested in this study may be natural alternative antimicrobial agents; however, further studies are required to better elucidate
the functional use of these proteins.
1. Introduction
Microorganisms are able to grow and adhere to many
surfaces, forming complex communities known as biofilms.
In biofilms, cells grow in multicellular aggregates that are
encased in a self-produced extracellularmatrix [1].Moreover,
it is known that these microcommunities exhibit distinct
phenotypes with respect to gene transcription, growth rate,
and enhanced resistance to antimicrobial agents [2–4].
Biofilms have been found to be involved in many chronic
diseases, such as chronic otitis, tonsillitis, cystic fibrosis,
periodontal diseases, and urinary tract infections [5–7].
Furthermore, biofilms can form on medical implants such
as catheters, artificial hips, and contact lenses, and, owing
to their increased resistance to antimicrobial agents, these
infections can often only be treated by removing the device [8,
9]. Compared to their planktonic counterparts, the microor-
ganisms in biofilms are less sensitive to biocides and antibi-
otics, complicating the management of device-associated
infections and limiting therapeutic options [10, 11]. Thus, the
discovery of new compounds that are able to eradicate such
biofilms is critical. In fact, in recent years, lectins have been
demonstrated to be active compounds against bacteria and
fungi in both planktonic cells and biofilms [12–14].
Lectins are a class of carbohydrate-binding proteins of
nonimmune origin which are organized into closely struc-
turally related families [15]. Although lectins were first found
in plants, they occur in all classes and families of organisms,
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from bacteria and viruses to mammals [16–18]. They are
responsible for deciphering sugar codes through complex
surface interactions and play a central role in a number of
biological processes, such as infections, cell communication,
and cell growth [19, 20]. Based on their capacity to bind
and recognize specific carbohydrates, lectins are involved in
several biological activities [21–25]. Although lectins have
sequence homology and structural similarities, they differ in
their various biological properties [26]. Thus, it is important
to identify new lectins with biotechnological potential as
antimicrobial and antibiofilm agents.
Lectins can recognize and reversibly bind to carbohy-
drates on cell surfaces and interact with cell wall polysaccha-
rides and/or glycoconjugates in the cell membrane [27, 28].
Moreover, lectins can interact with bacterial lipopolysaccha-
rides (LPS) or with the extracellular matrix of microorgan-
isms [29–31]. Some lectins have also shown antimicrobial
activity and are able to interferewith the formation of biofilms
[14, 32–36].
Thus, this work aimed to evaluate the in vitro antimicro-
bial activity of a set of plant and red algae lectins towards
clinically relevant microorganisms, including bacteria and
yeast.
2. Materials and Methods
2.1. Microorganisms. The microorganisms used in this study
included gram-positive bacteria: Staphylococcus epidermidis
CECT231 and Staphylococcus aureus JKD 6008, gram-
negative bacteria: Klebsiella oxytoca ATCC13182 and Pseu-
domonas aeruginosa ATCC 10145, and yeasts: Candida albi-
cans ATCC90028 and Candida tropicalis ATCC750, which
were obtained from the Coleccio´n Espan˜ola de Cultivos
Tipo (CECT) and the American Type Culture Collection
(ATCC). The S. aureus strain JKD6008 is a clinical isolate
that has developed resistance to vancomycin (vancomycin-
intermediate S. aureus (VISA)) [37].
2.2. Lectins Purification. The plant and algae lectins were
isolated by different chromatographic techniques including
affinity and ion exchange chromatographies. The references
for purification are described as follows: Dioclea megacarpa
lectin (DML) [38], Dioclea rostrata lectin (DRL) [39], Dio-
clea guianensis lectin (DGL) [40], Dioclea violacea lectin
(DVL) [41], Cratylia floribunda lectin (CFL) [42], Vatairea
macrocarpa lectin (VML) [43], Bauhinia bauhinioides lectin
(BBL) [44], Luetzelburgia auriculata agglutinin (LAA) [45],
Bryothamnion seaforthii lectin (BSL) [46], and Hypnea mus-
ciformis lectin (HML) [47].
2.3. Culture Conditions. The bacteria were grown in Tryp-
ticase Soy Agar medium (TSA, Liofilchem, Italy) and incu-
bated at 37∘C for 24 h. After growth on solid medium, an
isolated colony was removed and inoculated into 10mL of
Trypticase Soy Broth (TSB, Liofilchem, Italy) and incubated
for 18 h at 37∘C under constant agitation at 120 rpm. Prior
to use, the cell concentration of each inoculum was adjusted
to 2 × 106 cells/mL using a spectrophotometer (620 nm)
and the calibration curves previously determined for each
bacterium. The yeast culture conditions were the same as
those previously mentioned; however, the media included
Sabouraud Dextrose Agar and Broth (SDA and SDB, respec-
tively; Liofilchem, Italy), and the concentration of each yeast
inoculum was adjusted to 2 × 106 cells/mL using a Neubauer
chamber.
2.4. Planktonic Growth Assays. The effects of lectins on
planktonic growth were determined by the broth microdi-
lution method in 96-well polystyrene plates. Briefly, lectins
were diluted in culture medium (SDB for yeasts and TSB
for bacteria) to concentrations of 31.25 to 250𝜇g/mL, and
100 𝜇L of each lectin was incubated with 100 𝜇L of each
microorganism (previously adjusted to 2 × 106 cells/mL).
In order to provide a negative control, similar assays were
performed without lectins. All plates were incubated at 37∘C
for 24 h at 120 rpm, and optical density of each well was
recorded at 640 nm (OD
640
) using an automated microplate
reader (Synergy TM HT Multidetection Microtiter Reader).
The inhibition of planktonic growth by lectins was classified
as weak growth inhibition (10–40% of inhibition), medium
growth inhibition (40–80% of inhibition), or strong growth
inhibition (80–100% of inhibition).
2.5. Biofilm Assays. Bacterial and yeast biofilms were grown
in microtiter plates as previously described by Stepanovic et
al. [48], with some modifications. Briefly, lectins at concen-
trations ranging from 31.25 to 250 𝜇g/mL were added to the
plates containing microorganisms at 2 × 106 cells/mL. The
plates were then incubated on a horizontal shaker (120 rpm)
at 37∘C for 24 h for biofilm development. Afterwards, the
content of each well was removed, and biofilms were washed
twice with 200𝜇L of well sterilized water to remove weakly
adherent cells. In order to remove biofilm-entrapped bacte-
rial cells, 200𝜇L of sterile water was added to each well and
plates were placed in an ultrasonic bath operating at 50 kHz
for 6min (Sonicor Instruments, Copiague, NY, USA). For
the yeast biofilms, each well was scraped vigorously with a
pipette tip. Both procedures were previously well established
in the laboratory. Serial decimal dilutions from the obtained
suspensions were plated on TSA or SDA (depending on the
microorganism) to verify the number of viable cells in the
biofilms.The agar plates were then incubated for 24 h at 37∘C,
and the total number of colony-forming units (CFU) per unit
area (log CFU/cm2) of the well was counted.
The biofilm biomass was quantified by crystal violet
staining method. For the fixation of biofilms, 200𝜇L of 99%
methanol (Romil, UK) was added to each well, and after
15min themethanolwas removed and the plateswere allowed
to dry at 25∘C. Then, 200𝜇L of crystal violet stain (Merck,
Germany) was added to each well. After 5 min, the unbound
dye was removed and wells washed twice with water. Finally,
200𝜇L of acetic acid (33%, v/v) (Pronalab, Portugal) was
added to all wells to dissolve the crystal violet stain, and the
optical density was measured at 570 nm (OD
570
).
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2.6. Statistical Analysis. Statistical analyses were performed
by GraphPad Prism version 5.0 software from Microsoft
Windows. The data from all the assays were compared using
one-way analysis of variance (ANOVA) with the Bonferroni
post hoc test. 𝑃 < 0.01 was considered to be statistically
significant.
3. Results
3.1. Lectin Purification. The purities of the lectins were deter-
mined by SDS-PAGE, as shown in Figure 1. The Diocleinae
lectins displayed a pattern of subunits characteristic of the
lectins from that subtribe. The proteins migrated as three
bands, consisting of the full-length intact polypeptide chain
(𝛼-chain) and two fragments, 𝛽 and 𝛾. VML migrated as
four bands, twomajor bands (double bands) of approximately
34 and 32 kDa (𝛼-chains) and two minor bands of 22 and
13 kDa (the 𝛽- and 𝛾-chains, resp.). LAA migrated as two
major bands of 29 kDa (double bands) and two minor bands
at approximately 15 kDa. A different pattern was observed for
BBL, which exhibited only one band of approximately 32 kDa.
Regarding the algae lectins, BSL and HML exhibited only
one band of approximately 10 kDa. Furthermore, all lectins
showed hemagglutinating activity against rabbit erythrocytes
and were fully inhibited by 100mM D-glucose (Diocleinae
lectins), 100mMD-galactose (VML, LAA, and BBL), and the
glycoprotein porcine stomach mucin (algae lectins).
3.2. Effect of Lectins on Planktonic Growth. From all the
lectins tested, only 5 (CFL, VML, BBL, HML, and BSL) pre-
sented any effect against one or more of the microorganisms.
Although these 5 plant and algae lectins were not effective
against all bacteria and yeasts, they were all selected for the
biofilm assays (Table 1).
CFL at 250𝜇g/mL moderately inhibited the planktonic
growth of S. aureus; however, the lowest concentrations of this
protein showed weak inhibition. CFL also weakly reduced
the growth of S. epidermidis at 250 and 125 𝜇g/mL. CFL was
not able to reduce the growth of the gram-negative bacteria.
For the yeasts, CFL moderately inhibited C. albicans at all
concentrations, but no effect on C. tropicalis was observed.
Both of the D-galactose-specific lectins (VML and BBL)
caused some reduction in the planktonic growth of the
microorganisms. VML at 250𝜇g/mL completely inhibited
the planktonic growth of S. aureus and S. epidermidis. VML
was also able to inhibit, albeit weakly, the growth of P.
aeruginosa and C. albicans. No effect of BBL was observed
against S. epidermidis, and only weak inhibition of the other
microorganisms was observed.
The algae lectins HML and BSL caused weak growth
reductions in S. aureus, S. epidermidis, and P. aeruginosa.
Only HML reduced the growth of K. oxytoca. Neither of the
algae lectins reduced the yeast growth.
3.3. Effect of Lectins on Biofilm Mass and the Number of
CFUs. The effects of the lectins on the biomass and the
number of biofilm viable cells are shown in Figures 2, 3,
4, and 5. Interestingly, the lectins were able to prevent the
establishment of biomass in the biofilms of the bacteria
whose planktonic growthwas also sensitive to the lectins.The
plant lectins CFL and VML were able to inhibit the biomass
formation of S. aureus in biofilms (Figure 2(a)), but onlyVML
was able to influence biofilm formation in S. epidermidis
at the concentration of 250𝜇g/mL (Figure 2(b)). BSL could
decrease the biofilm mass of S. aureus at all concentrations
(Figure 2(a)); however, HML only caused a small decrease
at the highest concentrations (Figure 2(a)). Regarding the
gram-negative bacteria, CFL, BBL, and the algae lectins were
able to reduce the biomass of K. oxytoca to different extents
(Figure 2(d)). At 250𝜇g/mL, CFL and HML reduced the
biomass of the P. aeruginosa biofilm (Figure 2(c)). Although
some lectins inhibited the planktonic growth of the yeasts, no
lectin was able to reduce the yeast biofilm mass (Figure 3).
After incubating the microorganisms with the lectins for
24 hours, the number of cells was evaluated and expressed as
log CFU/cm2 (Figures 4 and 5). Similar to the reduction of
biomass observed for S. aureus and S. epidermidis, a decrease
in the number of viable cells in the biofilmwas observed in the
presence of the highest concentration of VML (Figure 4(a)).
Moreover, HML and BSL caused a small decrease in the
number of viable cells of S. aureus (Figure 4(a)), as did CFL
and BBL for S. epidermidis (Figure 4(b)). Interestingly, the
lectins were unable to decrease the number of viable cells of
gram-negative bacteria (Figures 4(c) and 4(d)). Regarding the
yeasts, only CFL was able to decrease the number of viable
cells in the C. albicans biofilms (Figure 5(a)).
4. Discussion
This work investigated the effect of plant and algae lectins
on planktonic growth and biofilm formation in both bacteria
and yeast. The observed effects of VML on the planktonic
growth of S. aureus, S. epidermidis, and the gram-positive
bacteria agreed with the results of other studies [13, 49, 50],
which have reported that the lectins isolated from the seeds
of Eugenia uniflora (EuniSL) and from the heartwood of
Myracrodruon urundeuva display activity against S. aureus at
low concentrations of 1.5 and 0.58𝜇g/mL, respectively.On the
other hand, Costa et al. [51] demonstrated that the Phthirusa
pyrifolia leaf lectin (PpyLL) has an MIC at 250𝜇g/mL to
S. epidermidis, while it does not inhibit the growth of S.
aureus. Regarding the gram-negative bacteria, the lectins
tested in this study had weak or no effects on planktonic
growth (Table 1).The above-referenced EuniSL and the lectin
from M. urundeuva exhibited MICs of 5 and 4.68 𝜇g/mL to
P. aeruginosa, respectively, while PpyLL did not have any
activity against this bacterium [49–51]. Moreover, the lectin
isolated from the seaweed Solieria filiformis [52] reduced the
planktonic growth of P. aeruginosa, as well as that of other
species of gram-negative bacteria, by approximately 25%, but
only at concentrations of 1mg/mL. These differences in the
concentrations of the lectins on the reduction of bacterial
growth most likely resulted from differences in the strains
tested or in the sugar specificity of the different lectins.
The mechanisms by which lectins exert their activity are
not well described, but it is believed that their antibacterial
activity against gram-positive and gram-negative bacteria
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Figure 1: SDS-polyacrylamide gel electrophoresis (15%) (a) Plant lectins. Line 1: Molecularmass markers; line 2: DML; line 3: DRL; line 4:
DGL; line 5: DVL; line 6: CFL; line 7: VML; line 8: BBL and line 9: LAA. (b) Algae lectins. Line 1: Molecular mass markers; line 2: BSL and
line 3: HML.
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Figure 2: Effects of lectins on the biofilm biomasses of Staphylococcus aureus JKD6008 (a); Staphylococcus epidermidis CECT231 (b);
Pseudomonas aeruginosa ATCC10145 (c) and Klebsiella oxytoca ATCC13182 (d). ∗𝑃 < 0.01 relative to control.
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Figure 3: Effects of lectins on the biofilm biomasses of Candida albicans ATCC90028 (a) and Candida tropicalis ATCC750 (b). ∗𝑃 < 0.01
relative to control.
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Figure 4: Effects of lectins on the number of viable cells in the biofilms of Staphylococcus aureus JKD6008 (a); Staphylococcus epidermidis
CECT231 (b); Pseudomonas aeruginosa ATCC10145 (c) and Klebsiella oxytoca ATCC13182 (d). ∗𝑃 < 0.01 relative to control.
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Figure 5: Effects of lectins on the number of viable cells in the biofilms of Candida albicansATCC90028 (a) and Candida tropicalisATCC750
(b). ∗𝑃 < 0.01 relative to control.
occurs through interactions of the lectins with components
of the bacterial cell wall, including teichoic and teichuronic
acids, peptidoglycans, and lipopolysaccharides [12, 53].
Interestingly, the lectins of the genusDioclea and CFL are
homologous, but only CFL reduced the planktonic growth
of the microorganisms. These lectins belong to the subtribe
Diocleinae and have a high degree of structural similarity and
the same specificity [29]. Despite their high similarity, these
lectins induce different responses in biological assays [54, 55].
According to Cavada et al. [26], the differences in biological
activity among Diocleinae lectins may result from small
changes in the relative orientations of their carbohydrate-
binding sites, their binding specificity for complex carbohy-
drates, or their pH-dependent oligomerization state. These
factors may explain the observation that only CFL reduced
the growth of the microorganisms, while the homologous
lectins exhibited no such activity (Table 1).
Despite displaying identical sugar specificity (D-
galactose), VML and BBL also showed different activities
against the growth of the microorganisms (Table 1), and
their different characteristics may account for their different
activities, such as fine variations in their sugar specificities.
Furthermore, VML was presented as an N-glycoprotein
[56]; however, Silva et al. [44] showed that BBL is not a
glycoprotein using sugar analysis.
In this study, the D-galactose-specific lectins VML and
BBL were able to weakly reduce the growth of C. albicans
(Table 1). According to Santana et al. [57], the lectin isolated
from Opuntia ficus cladodes is able to affect the growth
of C. albicans, reducing fungal growth by approximately
59%. According to Wong et al. [36], lectins do not directly
inhibit fungal growth by changing the structure and/or
permeability of the fungal membrane but rather by indirect
effects produced by the binding of the lectins to carbohydrates
BioMed Research International 7
on the surface of the fungal cell wall. On the other hand,Melo
et al. [58] showed that the lectin isolated from Luetzelburgia
auriculata (LAA) inhibits the fungal growth of Saccharomyces
cerevisiae. Using transmission electronic microscopy, the
authors observed the presence of lectins in the outer portion
of the cell wall and in the inner surface of the yeast cell
wall bordering the cell membrane. Moreover, their results
suggested that the lectin can interfere with the intracellular
transport of protons to the external environment [58].
In general, the different lectins were able to reduce
the biomass of some bacteria, often in a concentration-
dependent manner (Figure 2). For planktonic growth, VML
at 250 𝜇g/mL was able to reduce the biomass of S. aureus and
S. epidermidis. CFL also showed a reduction in the biomass of
K. oxytoca and P. aeruginosa, but BBL only showed a reduc-
tion in K. oxytoca. VML was more effective at 250 𝜇g/mL
(Figure 2). Cavalcante et al. [55] also showed that the lectin
isolated from the seeds of Canavalia maritima (ConM) was
able to reduce the biomass of Streptococcus mutans biofilms
when applied at a concentration of 200𝜇g/mL, which is a
concentration similar to that used in this work.
Some lectins isolated from algae have also shown activity
against bacterial biofilm formation. For example, lectins from
the red algae Bryothamnion triquetrum and Bryothamnion
seaforthii were able to attach to the acquired pellicle and
reduce the adherence of streptococci strains at 100𝜇g/mL
[33].
Lectins can cause bacterial aggregation [51, 59–61]. Lil-
jemark et al. [62] suggested that the formation of large
aggregates causes a decrease in the number of adherent
bacteria, which may explain why some of the lectins tested
in this study inhibited biofilm formation instead of reducing
bacterial growth. Moreover, some studies have indicated
that biofilm formation is directly related to the type of LPS
produced by the bacteria [63]. Because lectins are able to
interact with bacterial LPS [30, 31], the abilities of some
lectins to inhibit biofilm formation in gram-negative bacteria
may result from interactions between the lectin and LPS,
affecting the adherence of these bacteria and thus influencing
biofilm formation.
Interestingly, the lectins used in this study reduced the
number of viable cells in only the gram-positive bacteria, and
only CFL was able to decrease the number of viable cells of
C. albicans (Figure 2). Most likely, the reduced number of
viable cells in the biofilms of S. aureus and S. epidermidis by
VML and in those of C. albicans by CFL was caused by the
inhibition of the planktonic growth of the microorganisms.
Lakhtin et al. [35] showed that lectins of bifidobacterial
species and lactobacillus displayed destructive properties
towards C. albicans and S. aureus biofilms. According to
that author, in the presence of the lectins, C. albicans and
S. aureus biofilm degradation occurs in sequential steps,
including biofilm refinement, the appearance of edge cavities,
segmentation, the detachment of fragments, and, finally, lysis
[35].
In summary, some of the lectins tested here were able
to inhibit planktonic growth and/or biofilm formation in
the microorganisms. Moreover, the most promising lectins
showed differences in activity, which can be explained by
the different characteristics of these proteins. On the basis of
these findings, further studies will be required to investigate
the probable mechanisms of action of these lectins against
microorganisms as well as search for new antimicrobial
lectins.
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